Rakuten AI
Rakuten AI
Who We Are
About Us
Careers
English
日本語
Development of a novel, cellular-level drug uptake quantification pipeline for accurate estimation of fluorescence-conjugated therapeutics: Data from the Phase 1b/2 open-label study ASP-1929-181
11月 2, 2023
—
by
ar-mami.a.chappey@rakuten.com
in
Moonshot Programs
←
Previous:
Development of an image-based tumor microenvironment analysis coupled with peripheral flow cytometry reveals a distinct immune cell phenotype in responder patients in the Phase 1b/2 study ASP-1929-181
Next:
HYPA: Hybrid Horizontal Pod Autoscaling withAutomated Model Updates
→